<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FOR THE QUARTERLY
PERIOD ENDED APRIL 30, 1997 AND IS QUALIFIED BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<CIK> 0000316253
<NAME> ENZO BIOCHEM, INC.
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUL-31-1997
<PERIOD-START>                             AUG-01-1996
<PERIOD-END>                               APR-30-1997
<CASH>                                           23,665  
<SECURITIES>                                          0
<RECEIVABLES>                                    21,105
<ALLOWANCES>                                     (9,578)
<INVENTORY>                                       1,720
<CURRENT-ASSETS>                                 43,938
<PP&E>                                            9,006
<DEPRECIATION>                                   (6,113)
<TOTAL-ASSETS>                                   65,888
<CURRENT-LIABILITIES>                             1,790
<BONDS>                                               0
<PREFERRED-MANDATORY>                                 0
<PREFERRED>                                           0
<COMMON>                                            232
<OTHER-SE>                                       90,271
<TOTAL-LIABILITY-AND-EQUITY>                     65,888
<SALES>                                          24,621
<TOTAL-REVENUES>                                 24,621
<CGS>                                            10,964
<TOTAL-COSTS>                                    14,249
<OTHER-EXPENSES>                                 10,447
<LOSS-PROVISION>                                  3,802
<INTEREST-EXPENSE>                               (1,551)
<INCOME-PRETAX>                                     959
<INCOME-TAX>                                         25
<INCOME-CONTINUING>                                 934
<DISCONTINUED>                                        0
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                        934
<EPS-PRIMARY>                                       .04
<EPS-DILUTED>                                       .04